DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 197 filers reported holding DENALI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,175 | -17.1% | 268 | 0.0% | 0.00% | – |
| Q4 2022 | $7,453 | -82.7% | 268 | -80.8% | 0.00% | -100.0% |
| Q3 2022 | $43,000 | -24.6% | 1,398 | -28.3% | 0.00% | 0.0% |
| Q2 2022 | $57,000 | -9.5% | 1,951 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $63,000 | -28.4% | 1,948 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $88,000 | +363.2% | 1,948 | +414.0% | 0.00% | +200.0% |
| Q3 2021 | $19,000 | -34.5% | 379 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $29,000 | – | 369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |